Brenda Ferril, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 200 Mountain View St, St Ignatius, MT 59865 Phone: 406-745-3131 |
News Archive
Researchers review the various properties and use of nanoparticles in targeting SARS-CoV-2 and how they could be used to develop new therapeutics and diagnostics for SARS-CoV-2.
On Sept. 19, a research report by Helsinki University of Technology, Laboratory of Computational Engineering scientists will appear in the online, open-access journal PLoS ONE, showing that selective attention increases both gain and feature selectivity of the human auditory cortex.
Emergent BioSolutions Inc. announced today that the Phase I clinical trial for its anthrax monoclonal antibody therapeutic has commenced with the dosing of the first subject. Emergent's fully human monoclonal antibody product candidate is being developed as a parenteral post-exposure therapeutic to treat symptoms of inhalational anthrax disease.
LEO Pharma A/S, a global pharmaceutical company specialising in dermatology, has entered into an exclusive research and license agreement with the German biotech company 4SC Discovery GmbH with the primary aim of jointly researching, developing and commercialising an oral treatment for inflammatory skin diseases such as psoriasis.
› Verified 6 days ago